-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
June 26, 2018 - Pharmacologic treatments for osteoporosis inhibit osteoclastic bone resorption (antiresorptive agents … Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. … TBS (trabecular bone score) and diabetes-related fracture risk. … disease, i living in a nursing home, i COPD, i cancer, i lupus, i anticonvulsant use, i type 1 diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening-2010
January 15, 2010 - Limited evidence suggests that these improvements can be sustained over the year after treatment. … have a sizeable health impact. 5 , 6 Obese children and adolescents have an increased risk of type 2 diabetes … Multicomponent behavioral interventions and interventions that combined behavioral and pharmacologic treatments … Surgical treatments, which are reserved for morbidly obese patients who are identified without the need … Combined Pharmacologic and Behavioral Interventions
Seven trials combined pharmacologic treatments
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/osteoporosis-screening
January 14, 2025 - Diabetes Study phase I. … Diabetes Care . 2019;42(1):102-109. doi:10.2337/dc18-1486 67. … Optimal fracture prediction thresholds for therapy onset, established from FRAX and Garvan algorithms … TBS (trabecular bone score) and diabetes-related fracture risk. … Fracture risk and zoledronic acid therapy in men with osteoporosis.
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/integrating-evidence-based-clinical-and-community-strategies-improve-health
March 12, 2021 - M.P.H. h
The authors of this article are responsible for its contents, including any clinical or treatment … preventable burden of disease, that is, the amount of disease that could be averted if preventive and therapeutic … considered by both Task Forces including tobacco use, motor vehicle occupant injuries, physical activity, diabetes … Comprehensive tobacco treatment programs based in clinics and community settings modeled after CDC and … country to implement and evaluate chronic disease prevention projects focused on reducing the burden of diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening
February 25, 2020 - disease in white and Asian populations. 10 Other risk factors include cardiovascular risk factors (eg, diabetes … Pharmacologic treatments approved by the US Food and Drug Administration for Alzheimer disease include … (eg, loss of function and relationships, financial misjudgments, and nonadherence with recommended therapies … Since current medical therapies for dementia do not appear to affect its long-term course, the potential … Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary22/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation-september-2015
March 30, 2015 - Iron supplement in pregnancy and development of gestational diabetes—a randomised placebo-controlled … Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev . 2011:CD003094. … Treatments for iron deficiency anaemia in pregnancy. Cochrane Database Syst Rev . 2001:CD003094. … A subsequent arrow from treatment examines the resulting harms of treatment. … Control
Gestational Diabetes
Pregnancy-Induced
Hypertension
GI Events
Other
Barton
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/food-insecurity-screening
March 11, 2025 - Studies were excluded if 50% or more of participants were undergoing cancer treatment, had other acute … Medically tailored meal delivery for diabetes patients with food insecurity: a randomized cross-over … A pilot food bank intervention featuring diabetes-appropriate food improved glycemic control among clients … The impact of a produce prescription programme on healthy food purchasing and diabetes-related health … A collaborative pilot to support patients with diabetes through tailored food box home delivery.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
March 02, 2020 - Sustained virologic response after antiviral therapy was consistently associated with decreased risk … Direct-acting antiviral regimens are associated with fewer harms than older interferon-containing therapies … for headache and were also lower when compared with rates reported for older interferon-containing therapies … function, and extrahepatic effects of HCV infection (eg, renal function, cardiovascular effects, or diabetes … Currently recommended DAA regimens are associated with fewer harms than older interferon-containing therapies
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
May 02, 2023 - isoniazid and 1.1% for rifampin. 131 Meta-analysis found no statistically significant difference between treatments … It is unclear whether changes in the prevalence of tuberculosis (which has decreased), treatments for … noninferiority, improved adherence, and lower risk of hepatotoxicity for current, CDC-preferred LTBI treatments … The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
February 11, 2025 - Development and validation of a simple hip fracture
risk prediction tool for type 2 diabetes: the
Fremantle … Diabetes Study phase I. … Diabetes Care.
2019;42(1):102-109. doi:10.2337/dc18-1486
67. … TBS (trabecular
bone score) and diabetes-related fracture risk. … Fracture risk and zoledronic acid therapy in men
with osteoporosis.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - Good evidence indicates that both the testing strategy and the treatment with carotid endarterectomy … Because the magnitude of potential surgical harms is such an important consideration in the treatment … study, and would not have included treatments that are now considered to be optimal medical management … It is difficult to determine what effect current standard medical therapy would have on overall benefit … individuals age 55 years or older with cardiovascular risk factors, such as a history of hypertension, diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
July 15, 2008 - uncertain" and recommended further research into the implications of using CRP in risk categorization for therapeutic … factor in global risk assessment for incident CHD is limited by sparse evidence that directly links therapeutic … risk score greater than 20%, diabetes, or known cardiovascular disease. … High Blood Cholesterol in Adults (Adult Treatment Panel III). … Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-pregnant-women1/human-immunodeficiency-virus-hiv-infection-screening
June 11, 2019 - declined after the widespread adoption of routine prenatal screening, coupled with the use of effective therapies … Effectiveness of Treatment
Key Question 4. … Harms of Treatment
Key Question 5. … (n = 4117) that found receipt of ART during pregnancy associated with increased risk of gestational diabetes … There was no increased risk in all-cause mortality, anemia, or diabetes among ART regimens. 80 There
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/UXw277rnvJ8e_Dfsh4V3K3
July 26, 2022 - lifestyle counseling,4,5 tobacco
cessation,6 weight loss,7 aspirin use,8 statin use,9 and screening for
and treatment … incidence of musculoskeletal injuries, fractures, or
falls and found primarily no differences between treatment … The
behavioral and clinical effects of therapeutic
lifestyle change on middle-aged adults. … Behavioral
treatment for weight gain prevention among black
women in primary care practice: a randomized … Reducing diabetes risk in American Indian women.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Effects of aspirin for primary prevention in persons with diabetes mellitus. … AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic … Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy … Association of aspirin use with major bleeding in patients with and without diabetes. … of High Blood Cholesterol in Adults (Adult Treatment Panel III).
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/PdBbRgWKPMbHfeQeHkM242
February 01, 2010 - have a size-
able health impact.5,6 Obese children
and adolescents have an increased
risk of type 2 diabetes … Multicomponent behavioral in-
terventions and interventions that
combined behavioral and pharmaco-
logic treatments … Surgical treatments, which are re-
served for morbidly obese patients
who are identified without the … Combined Pharmacologic and
Behavioral Interventions
Seven trials combined pharmacologic
treatments ( … Obesity evaluation and
treatment: Expert Committee recommenda-
tions. Pediatrics. 1998;102(3).
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/DCfAJZvNDzSYu7NqLJX2bv
March 01, 2016 - for wet AMD (laser
photocoagulation and photodynamic therapy). … 1 Screening conducted by an optometrist
(in 2 articles)
2 Laser photocoagulation and
photodynamic therapies … or 4 AMD.
f Adjusted for age; sex; race; education; smoking status; body mass index; and presence of diabetes … Conclusions from the 2009 USPSTF review regarding the
effectiveness of treatments vs no treatment for … Research is also needed to understand
the effectiveness of new therapies that are being investigated
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary19/high-blood-pressure-in-adults-screening-monitoring-october-2015
December 22, 2014 - certain outcomes (such as angina or revascularization) or populations with comorbid conditions (such as diabetes … Diabetes Res Clin Pract . 2014;103:51-6. [PMID: 24398319
93. … The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and … Lee JH, Yang DH, Park HS, Cho Y, Jun JE, Park WH, et al; Hypertension-Diabetes Daegu Initiative Study … * Defined as the threshold for pharmacologic treatment.
Text Description .
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/h5Tt4jScmQJeHeztmo93hu
February 25, 2020 - disease in white and Asian
populations.10 Other risk factors include cardiovascular risk factors
(eg, diabetes … Pharmacologic treatments approved by the US
Food and Drug Administration for Alzheimer disease include … (eg, loss of function and relationships, financial misjudgments, and
nonadherence with recommended therapies … Since current medical therapies for dementia
do not appear to affect its long-term course, the potential … Screening for abnormal blood glucose and type 2
diabetes mellitus: U.S.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
September 06, 2016 - For each included study, one investigator extracted information
about design, population, tests or treatments … The combina-
tion therapy was found to be noninferior to isoniazid-only treat-
ment. … Limited usefulness of QuantiFERON-TB Gold
In-Tube for monitoring anti-tuberculosis therapy. … The sensitivity of interferon-gamma release assays
is not compromised in tuberculosis patients with
diabetes … Adverse
events with 4 months of rifampin therapy or 9
months of isoniazid therapy for latent tuberculosis